14 July 2016 in Ophthalmologica
The objective of this study was to assess the intraocular pressure (IOP) as well as the anatomical modifications of the anterior segment following an aflibercept injection. Patients underwent an aflibercept intravitreal injection (IVI) (0.05 ml) with a 30.5-gauge needle and an antireflux system. IOP was assessed before injection (T0), immediately after (T1), and 5 min (T5), 15 min (T15), and 45 min (T45) after the IVI. Before the IVI and immediately after the T1 measurement, a PENTACAM® acquisition was used to evaluate the anterior chamber parameters (anterior chamber volume, depth and measure of the iridocorneal angle). At T0, IOP was 12.9 ± 1.3 mm Hg. IOP significantly increased after IVI (42.7 ± 3 mm Hg, p < 0.001). IOP returned to baseline at T45 (13.0 ± 1.2 mm Hg, p = 0.877). Anterior chamber volume decreased after IVI (160.6 vs. 168.3 mm3, p = 0.002). No significant changes were found for iridocorneal angle and anterior chamber depth. Aflibercept IVI causes an acute increase in IOP over a short period without iridocorneal angle closure.
6 September 2018 in Acta Ophthalmologica
1 January 2020 in Journal of Cataract & Refractive Surgery
Purpose: Iris intraocular implants were developed to manage congenital or traumatic iris defects. However, they are also used to change the color of patient eyes. The aim of this retrospective series was to report complications in patients managed in France after cosmetic implantation. Setting: Ophthalmological institutions and private ophthalmologists in France. Design: Multicenter retrospective observational study. Methods: Questionnaires were sent to all ophthalmology departments in university hospitals and to private ophthalmologists. This questionnaire listed demographic and clinical data for each implanted eye with a focus on safety, the description of ocular complications (corneal edema, endothelial cell loss, increased intraocular pressure, and intraocular inflammation), and the therapeutic management implemented. Results: Forty-four questionnaires (87 eyes) were collected, and ultimately, 33 questionnaires (65 eyes) were considered complete and analyzed. Two types of implants were identified. Of the 65 eyes analyzed, only 5 eyes (7.7%) did not experience any complication and 60 eyes (92.3%) had at least 1 complication. The most commonly reported complication was corneal decompensation (78.5%). The diagnosis of glaucoma was made in over half (52.3%) of the cases. Explantation was needed in 81.5% of cases. The mean final visual acuity was 0.45 ± 0.08 logarithm of the minimum angle of resolution (logMAR) (0 to 2 logMAR). Conclusions: Several ocular complications with a decreased mean visual acuity were described in a young healthy population. In addition, patient information on the safety of this procedure appeared insufficient.
7 October 2018 in European Journal of Ophthalmology
The technological improvements in optical biometers have made cataract surgery evolve to the level of refractive surgery. This study assessed the correlation and agreement between a biometer using swept-source optical coherence tomography technology (IOLMaster 700; Carl Zeiss Meditec, Jena, Germany) and a biometer using optical low-coherence reflectometry (Lenstar; Haag Streit, Koeniz, Switzerland). Optical biometric measurements were taken with the IOLMaster 700 and the Lenstar on 129 eyes of 129 patients referred for cataract surgery. We compared biometric data (axial length, mean keratometry, central pachymetry, anterior chamber depth, lens thickness, and horizontal white-to-white measurement) and the emmetropic intraocular lens power calculated with SRK/T and Haigis formulas. Correlation and agreement for these parameters were evaluated. Only anterior chamber depth measurements (3.05 ± 0.07 vs 3.07 ± 0.07, p < 0.001) and the white-to-white measurement (11.97 ± 0.07 vs 12.06 ± 0.07, p < 0.001) differed significantly between the machines. Correlations and agreements were excellent, with perfect agreement for axial length measurement (r = 1, intraclass correlation coefficient = 1). Emmetropic intraocular lens power did not differ between devices with SRK/T formula (20.94 ± 0.51 vs 20.92 ± 0.50, p = 0.51). With Haigis formula, there was a statistically significant difference (21.04 ± 0.52 vs 20.84 ± 0.52, p < 0.001). This study suggests that there is a very high correlation and agreement for the biometric measurements and calculation of intraocular lens implant power with the SRK/T formula.
1 December 2012 in Journal Français d'Ophtalmologie
17 April 2020 in Acta Ophthalmologica
ZMZainab Machkour‐Bentaleb
+3